On May 11, 2026, three insiders at Viridian Therapeutics, Inc. (VRDN) executed significant stock purchases, collectively acquiring approximately $60 million worth of shares.
The transactions were made by entities associated with Fairmount, including Healthcare Fund Ii L.P., Funds Management Llc, and Healthcare Fund Ii Gp Llc. Each of these entities, identified as Directors and 10% Owners, purchased 1,176,470 shares at a price of $17.00 per share, totaling nearly $20 million for each purchase.
This cluster buying, where multiple insiders buy shares in close succession, is often viewed as a strong bullish signal by market observers. It suggests a shared conviction among key stakeholders regarding the company's future prospects.